Duchesnay Inc. et al v. Hetero Labs Limited et al
| QuatRx Pharmaceuticals Company, Duchesnay Inc. and Shionogi Inc. |
| Hetero Drugs Limited, Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V |
| 1:2021cv00538 |
| April 14, 2021 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 21, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 9 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero USA Inc. waiver sent on 4/15/2021, answer due 6/14/2021. (Joyce, Alexandra) |
| Filing 8 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero Labs Limited waiver sent on 4/15/2021, answer due 6/14/2021. (Joyce, Alexandra) |
| Filing 7 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero Labs Limited Unit-V waiver sent on 4/15/2021, answer due 6/14/2021. (Joyce, Alexandra) |
| Filing 6 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero Drugs Limited waiver sent on 4/15/2021, answer due 6/14/2021. (Joyce, Alexandra) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Shionogi & Co., Ltd. for Shionogi Inc.; Corporate Parent Shionogi Inc. for QuatRx Pharmaceuticals Company - filed by Duchesnay Inc., QuatRx Pharmaceuticals Company, Shionogi Inc. (kmd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,642,079. (kmd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/1/2021. Date of Expiration of Patent: 7/9/2028.Thirty Month Stay Deadline: 9/1/2023. (kmd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Filing 1 COMPLAINT for Patent Infringement filed against Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3593554.) - filed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) |
| No Summons Issued. (kmd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
